Evidence map›Paper›PMID 39511249›Full record

ArticleScientific reports2024

Author Correction: Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols.

Ruth Luthi-Carter, Sara Cappelli, Morgan Le Roux-Bourdieu, Noemie Tentillier, James P Quinn, Tiziana Petrozziello, Lathika Gopalakrishnan, Purva Sethi, Himanshi Choudhary, Giorgia Bartolini and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Ruth Luthi-CarterAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland. ruth.luthi-carter@acimmune.com.
Sara CappelliInternational Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149, Trieste, Italy.
Morgan Le Roux-BourdieuAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Noemie TentillierAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
James P QuinnMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Tiziana PetrozzielloSean M. Healey and AMG Center for ALS at MassGeneral, Massachusetts General Hospital, 165 Cambridge Street, Boston, MA, 02114, USA.
Lathika GopalakrishnanDepartment of Translational Neuroscience, Barrow Neurological Institute, 350 W. Thomas Road, Phoenix, AZ, 85013, USA.
Purva SethiKansas City University, 1750 Independence Ave, Kansas City, MO, 64106, USA.
Himanshi ChoudharyInternational Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149, Trieste, Italy.
Giorgia BartoliniAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Elias GebaraAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Cristiana StuaniInternational Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149, Trieste, Italy.
Laure FontAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Jiyan AnDepartment of Translational Neuroscience, Barrow Neurological Institute, 350 W. Thomas Road, Phoenix, AZ, 85013, USA.
Vanessa OrtegaDepartment of Translational Neuroscience, Barrow Neurological Institute, 350 W. Thomas Road, Phoenix, AZ, 85013, USA.
Jessica SageKansas City University, 1750 Independence Ave, Kansas City, MO, 64106, USA.
Edina KosaKansas City University, 1750 Independence Ave, Kansas City, MO, 64106, USA.
Bianca A TrombettaMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Roberto SimeoneDipartimento di Medicina Trasfusionale Giuliano-Isontina, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy.
Tamara SeredeninaAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Tariq AfrozAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
James D BerryMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Steven E ArnoldMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Becky C CarlyleMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Oskar AdolfssonAC Immune, SA (ACIU), EPFL Innovation Park Building B, 1015, Lausanne, Switzerland.
Ghazaleh Sadri-VakiliMassachusetts General Hospital Department of Neurology, 114 16th Street, Charlestown, MA, 02129, USA.
Emanuele BurattiInternational Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149, Trieste, Italy.
Robert BowserDepartment of Translational Neuroscience, Barrow Neurological Institute, 350 W. Thomas Road, Phoenix, AZ, 85013, USA.
Abdulbaki AgbasKansas City University, 1750 Independence Ave, Kansas City, MO, 64106, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39511249
PMCPMC11543669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.